Results 221 to 230 of about 681,929 (290)

Wild Birds' Genetic Resources Bank: Feather Follicle Cell Culture as a Possible Source of Stem Cells. [PDF]

Methods Protoc
Reis YGD, Guerra MEP, Coutinho MP, Santos SIP, Mota BD, Munhoz LLS, Rossetti DP, Martins DDS.   +7 more
europepmc   +1 more source

Wheat Genetic Resources in Nepal

, 1970
BK Joshi, Ashok Mudwari, MR Bhatta
openalex   +2 more sources

CX3CL1 in Early Detection of Alzheimer's Disease: Plasma Dynamics Across Age and Disease Stages

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Backgrounds Alzheimer's disease (AD) is characterized by amyloid‐beta plaques, tau tangles, and neuroinflammation. C‐X3‐C motif chemokine ligand 1 (CX3CL1, also known as fractalkine), a neuroimmune chemokine implicated in AD pathogenesis, shows inconsistent alterations in plasma/serum across studies.
Ling Wang, Yujie Liu, Fei Li, Xuelin Li, Lanlan Li, Jie Zhang, Yali Xu   +6 more
wiley   +1 more source

Editorial: Advances in conservation and utilization of plant genetic resources. [PDF]

Front Plant Sci
Solberg SØ, van Zonneveld M, Diederichsen A.   +2 more
europepmc   +1 more source

Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States

Arthritis Care &Research, EarlyView.
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley   +1 more source

Correction: Muñoz-Zavala et al. Aflatoxins in Mexican Maize Systems: From Genetic Resources to Agroecological Resilience and Co-Occurrence with Fumonisins. <i>Toxins</i> 2025, <i>17</i>, 531. [PDF]

Toxins (Basel)
Muñoz-Zavala C, Solís-Martínez O, Valencia-Luna JB, Sonder K, Hernández-Anguiano AM, Palacios-Rojas N.   +5 more
europepmc   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Arthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang, Sandra Blitz, Nick Bansback, Michael Law, Mark Harrison   +4 more
wiley   +1 more source

Development of robust constitutive synthetic promoter using genetic resources of plant pararetroviruses. [PDF]

Front Plant Sci
Sherpa T, Dey N.
europepmc   +1 more source

The state of poultry genetic resources and genetic diversity of hen populations

, 2011
Ewelina Semik‐Gurgul, J. Krawczyk
openalex   +1 more source

A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases

Arthritis Care &Research, EarlyView.
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah, Alexis Castellanos, Yen Chen, John Piette, Amy Bucher, Susan Murphy   +5 more
wiley   +1 more source